RankAlpha logo
Back to Rankings

DWTX

Dogwood TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
DWTX vs peer average
28/100
DWTX vs. peer average (F vs. D)
Grade spread
B 3 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ZYBT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $42.21M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerZYBTZhengye Biotechnology
DWTX
Dogwood Therapeutics
ZYBT
Zhengye Biotechnology
Grade
F
F
Momentum
15
79
Value
41
55
Sentiment
-
2
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs ZYBT

DWTX / ZYBT
Grade Position
Below peers
DWTX vs. peer average (F vs. D)
28/100
Momentum
15
ZYBT
Value
41
ZYBT
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs DWTX
1
ZYBT
Zhengye Biotechnology Holding Ltd Class A Common
F
20/100
Even
2
GRCE
Grace Therapeutics Inc Common
B
80/100
+3
3
INMB
INmune Bio Inc Common
F
20/100
Even
4
BTMD
biote Corp Class A Common
B
80/100
+3
5
ALDX
Aldeyra Therapeutics Inc Common
B
80/100
+3
ZYBT is the first peer returned for this comparison set.